Allianz Asset Management GmbH Grows Stake in Amedisys, Inc. (NASDAQ:AMED)

Allianz Asset Management GmbH boosted its stake in Amedisys, Inc. (NASDAQ:AMEDFree Report) by 146.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 39,855 shares of the health services provider’s stock after buying an additional 23,655 shares during the quarter. Allianz Asset Management GmbH owned approximately 0.12% of Amedisys worth $3,789,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Hilltop Holdings Inc. acquired a new stake in shares of Amedisys in the fourth quarter worth approximately $2,001,000. Norges Bank purchased a new position in Amedisys in the 4th quarter valued at $34,032,000. BNP Paribas Financial Markets lifted its holdings in Amedisys by 74.0% in the 4th quarter. BNP Paribas Financial Markets now owns 5,692 shares of the health services provider’s stock valued at $541,000 after purchasing an additional 2,421 shares in the last quarter. Mesirow Institutional Investment Management Inc. boosted its stake in Amedisys by 9.9% during the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 2,844 shares of the health services provider’s stock worth $270,000 after purchasing an additional 257 shares during the last quarter. Finally, Alpine Associates Management Inc. grew its holdings in shares of Amedisys by 23.0% during the fourth quarter. Alpine Associates Management Inc. now owns 1,271,097 shares of the health services provider’s stock worth $120,830,000 after buying an additional 237,600 shares in the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Trading Down 0.3 %

Shares of Amedisys stock opened at $91.45 on Friday. The stock has a 50 day moving average of $93.13 and a 200 day moving average of $93.66. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market capitalization of $2.99 billion, a price-to-earnings ratio of -142.89, a PEG ratio of 2.27 and a beta of 0.80. Amedisys, Inc. has a fifty-two week low of $89.55 and a fifty-two week high of $97.36.

Amedisys (NASDAQ:AMEDGet Free Report) last issued its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The firm had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. During the same period in the previous year, the firm earned $1.00 EPS. Amedisys’s revenue was up 2.7% on a year-over-year basis. As a group, research analysts predict that Amedisys, Inc. will post 4.57 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Raymond James restated a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. StockNews.com upgraded Amedisys from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. Royal Bank of Canada boosted their price objective on Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, March 25th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $101.00 target price on shares of Amedisys in a research note on Thursday, April 25th. Six analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Amedisys presently has a consensus rating of “Hold” and an average price target of $100.80.

Get Our Latest Stock Analysis on Amedisys

Amedisys Profile

(Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

See Also

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.